Wednesday, September 24, 2014

Gilead Investigational HIV Pill Meets Study Goals

Gilead Sciences said its new investigational combination pill for HIV met its primary study goals in two phase III studies.



from WSJ.com: US Business http://ift.tt/1xfBm0B

via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)